Pantoprazole Sodium DR Tablet
Pantoprazole Sodium DR is available as an FDA-approved commercial delayed-release tablet and as a compounded formulation, prepared by Mixlab for veterinary use in dogs. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
In humans, pantoprazole is FDA-approved for the treatment of erosive esophagitis associated with GERD and for long-term management of certain conditions involving excess stomach acid production. In veterinary medicine, pantoprazole is used off-label, most often when clinicians consider gastric acid suppression relevant to a patient's care, including in hospitalized animals receiving the medication intravenously.
At a pharmacological level, pantoprazole is a proton pump inhibitor that covalently binds to the hydrogen-potassium ATPase enzyme system — the "proton pump" — within the gastric parietal cells, suppressing both baseline and stimulated acid secretion into the stomach. The delayed-release formulation is enteric-coated, meaning it's designed to resist breakdown in the stomach's acidic environment so the medication is released and absorbed further along in the digestive tract; this is why delayed-release tablets should not be crushed or split unless your veterinarian specifically directs otherwise.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing, or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of pantoprazole may include mild gastrointestinal changes such as nausea, loose stools, or gas. This medication is typically avoided in animals with a known hypersensitivity to pantoprazole or other proton pump inhibitors, such as omeprazole. Because delayed-release tablets rely on their coating to work as intended, follow your veterinarian's specific instructions on whether the tablet can be given whole, split, or must remain intact; giving it roughly 30 minutes before a meal is a common approach, but your veterinarian will confirm the right timing for your pet.
Pantoprazole can interact with certain other medications, including some thyroid medications, blood thinners, and antifungal drugs, so provide your veterinarian with a complete list of everything your pet is taking. With long-term use in people, proton pump inhibitors have been associated with effects such as low magnesium levels and vitamin B12 changes; your veterinarian can advise on any monitoring appropriate for extended courses. Contact your veterinarian if you notice persistent vomiting, diarrhea, black or tarry stools, or a lack of appetite.
Yes. Pantoprazole is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all prescriptions before any medication is prepared or shipped.
Both may be available. Mixlab can dispense the FDA-approved commercial delayed-release tablet, or, when appropriate, compound the active ingredient into an alternative format if your veterinarian determines that better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Follow your veterinarian's specific instructions. The delayed-release coating is designed to protect the medication until it reaches a particular point in the digestive tract, so tablets are generally not crushed or split unless your veterinarian directs otherwise.
Both belong to the same drug class — proton pump inhibitors — and work through a similar mechanism of suppressing stomach acid production. Veterinarians may discuss factors like available dosage forms, including injectable options for hospitalized patients, when considering which proton pump inhibitor fits a particular situation.
